Dose: 3.571 to 7.142 mg/kg
Single Dose: 5.4 (5.3565)
Frequency: As recommended.
Route: IV
Instructions: Once or As Required

Hexobarbitone (Na) also known as Hexobarbital Na. . It is of Synthetic origin and belongs to Barbiturate. It belongs to Chloride Channel opener (Gaba operated) pharmacological group on the basis of mechanism of action and also classified in General Anesthetics pharmacological group.The Molecular Weight of Hexobarbitone (Na) is 258.30. Its pKa is 8.2.

Hexobarbitone (Na) is contraindicated in conditions like Anaemia,Septicaemia,Cancer,Liver diseases,Ileus hyperemesis.

The severe or irreversible adverse effects of Hexobarbitone (Na), which give rise to further complications include Grand-mal seizures, Abstinence syndrome, Grand-mal seizures.Hexobarbitone (Na) produces potentially life-threatening effects which include Bronchospasm, Bronchospasm, Fall in B.P., Laryngospasm, Respiratory difficulties, Coughing, Tissue damage. which are responsible for the discontinuation of Hexobarbitone (Na) therapy.The signs and symptoms that are produced after the acute overdosage of Hexobarbitone (Na) include Hypotension, Death, Respiratory depression, Renal failure, Poisoning, Peripheral vascular collapse, Feeble heart beat, Lowered body temperature.The symptomatic adverse reactions produced by Hexobarbitone (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Ataxia, Lethargy, Sedation, Slurred speech, Allergic skin reactions, Hangover, Nystagmus, CNS depression, Ataxia.

Hexobarbitone (Na) is primarily indicated in conditions like Insomnia.

Hexobarbitone (Na) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholRifampicinSomatostatinSomatostatin has been demonstrated to prolong or enhance the effects of Hexobarbitone (Na). These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.